New Pancreatic Cancer Treatment Cuts Side Effects by 70%

Pancreatic cancer patients now have access to a treatment that lets them fight the disease without sacrificing their quality of life.

Trans-Arterial Micro-Perfusion, or TAMP, delivers chemotherapy straight to the tumor through a tiny catheter inserted through the groin. Instead of poisoning the whole body with traditional IV chemotherapy, doctors guide the medication exactly where it needs to go.

"Very simply put, it is a way to deliver chemotherapy directly to a pancreatic cancer tumor," says Dr. Gregory Tiesi, Chief of Surgical Oncology at Jersey Shore University Medical Center in New Jersey. The hospital became the first in the state to offer the treatment.

The difference shows up immediately in how patients feel. Because healthy tissue barely comes into contact with the chemotherapy, people experience far fewer side effects like nausea, exhaustion, and hair loss.

The procedure itself happens in an outpatient setting under light sedation. Most people go home the same day and feel well during the two weeks between treatments, which typically run every other week for up to eight sessions.

Patients who aren't candidates for surgery yet sometimes see their tumors shrink enough to make operation possible. The concentrated dose can loosen the cancer's grip on nearby blood vessels, opening doors that seemed closed.

Dr. Tiesi recommends radiation before starting TAMP because it reduces small blood vessels around the tumor. That keeps more chemotherapy locked in place instead of washing away, making each treatment more powerful.

The Bright Side

Pancreatic cancer remains one of the hardest cancers to beat, but progress keeps building. When Dr. Tiesi started his career, the five-year survival rate sat at zero percent. Today it's climbed to 13 percent through incremental advances like TAMP.

The treatment works best for cancer that hasn't spread beyond the pancreas and nearby tissues. Not everyone qualifies, but for those who do, the chance to fight hard without feeling sick changes everything.

Between treatments, patients aren't constantly tethered to infusion centers or battling waves of nausea. They're living their lives while the medicine does its work.

The most common side effects in clinical trials were manageable: nausea, vomiting, and abdominal pain. Serious complications like infection or blood vessel problems remain rare.

Every cancer breakthrough matters, but ones that preserve dignity and daily joy while extending survival deserve celebration. TAMP represents both kinds of progress at once.